Table 4 Univariate and multivariate cox regression comparing resected patients with paraaortic lymph node metastasis (PALN+), or no paraaortic lymph node metastasis (PALN-).
Variable | Subtype | Hazard Ratio (95% conf. interval) | p-value | |
|---|---|---|---|---|
Univariate | Resection type* | PALN- | 0.55(0.29–1.01) | 0.05 |
Demographic | Female sex | 0.72(0.46–1.14) | 0.16 | |
Age | 1.01(0.98–1.03) | 0.51 | ||
Charlson Comorbidity Index | 1.06(0.97–1.16) | 0.21 | ||
Oncology treatment | Preoperative chemotherapy | 0.70(0.38–1.30) | 0.26 | |
Postoperative Chemotherapy | 0.56(0.33–0.93) | 0.02 | ||
Tumor T-stage# | T2 | 1.42(0.54–3.73) | 0.48 | |
T3 | 1.42(0.55–3.64) | 0.47 | ||
T4 | 1.01(0.12–9.19) | 0.95 | ||
Tumor N stage# | N1 | 1.46(0.76–2.80) | 0.26 | |
N2 | 2.02(0.99–4.100) | 0.06 | ||
Resection Result§ | R1 | 0.98(0.39–2.46) | 0.97 | |
R2 | 1.95(0.47–8.08) | 0.36 | ||
Multivariate | Resection type* | PALN- | 0.77(0.36–1.63) | 0.49 |
Demographic | Female sex | 0.87(0.48–1.56) | 0.63 | |
Age | 1.01(0.98–1.04) | 0.59 | ||
Charlson Comorbidity Index | 1.10(0.98–1.25) | 0.12 | ||
Oncology treatment | Preoperative chemotherapy | 0.85(0.33–2.23) | 0.74 | |
Postoperative Chemotherapy | 0.46(0.24–0.91) | 0.03 | ||
Tumor T-stage# | T2 | 0.90(0.40–3.10) | 0.84 | |
T3 | 1.01(0.35–2.8) | 0.98 | ||
T4 | 2.06(0.04–5.9) | 0.57 | ||
Tumor N stage# | N1 | 2.39(1.05–5.44) | 0.04 | |
N2 | 2.60(1.05–6.42) | 0.04 | ||
Resection Result§ | R1 | 0.82(0.28–2.43) | 0.72 | |
R2 | 2.86(0.61–13.48) | 0.18 |